# A Real-world Study on the Compliance of OFS-assisted Endocrine Therapy for Hormone Receptor-positive(HR+) Premenopausal Breast Cancer

> **NCT07180914** · — · NOT_YET_RECRUITING · sponsor: **Zhejiang Cancer Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Breast Cancer Females

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07180914
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-10
- **Primary completion:** 2029-07-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07180914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07180914, "A Real-world Study on the Compliance of OFS-assisted Endocrine Therapy for Hormone Receptor-positive(HR+) Premenopausal Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07180914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*